These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33371790)

  • 21. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
    Wu G; Zhang M
    BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
    Liu W; Xie X; Qi Y; Wu J
    JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma.
    Chen Q; Xing C; Zhang Q; Du Z; Kong J; Qian Z
    Sci Rep; 2024 Jun; 14(1):13790. PubMed ID: 38877061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
    Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
    Front Immunol; 2022; 13():997765. PubMed ID: 36275664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.
    Li J; Shi H; Yuan Z; Wu Z; Li H; Liu Y; Lu M; Lu M
    BMC Cancer; 2022 Jan; 22(1):108. PubMed ID: 35078433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
    Wang Q; Zhang W; Guo Y; Li Y; Fu K
    Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.
    Yang M; Su Y; Xu K; Zheng H; Yuan Q; Cai Y; Aihaiti Y; Xu P
    J Orthop Surg Res; 2023 Oct; 18(1):787. PubMed ID: 37858131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes.
    Feng L; Chen Y; Mei X; Wang L; Zhao W; Yao J
    Cancer Biother Radiopharm; 2024 Sep; 39(7):517-531. PubMed ID: 38512709
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
    Wang J; Gong M; Xiong Z; Zhao Y; Xing D
    J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPP1 could be an immunological and prognostic biomarker: From pan-cancer comprehensive analysis to osteosarcoma validation.
    Zhang Z; Liu B; Lin Z; Mei L; Chen R; Li Z
    FASEB J; 2024 Jul; 38(14):e23783. PubMed ID: 39037571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a novel immune-related genes prognostic signature for osteosarcoma.
    Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
    Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning.
    Wen B; Chen J; Ding T; Mao Z; Jin R; Wang Y; Shi M; Zhao L; Yang A; Qin X; Chen X
    Sci Rep; 2024 Aug; 14(1):18734. PubMed ID: 39134603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
    Dai Z; Liu Z; Yang R; Cao W; Ji T
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma.
    Zhang N; Han Y; Cao H; Wang Q
    J Cell Mol Med; 2024 May; 28(9):e18286. PubMed ID: 38742843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.